Week 4: Cardiology (5) (antiarrhythmic) Flashcards
rationale for antiarrhythmics
prevent dangerous and restore normal sinus rhythm and conduction
o Decrease conduction velocity
o Change duration of the effective refractory period (ERP)
o Supress abnormal automaticity
classification system of antiarrhythmics
vaughan williams classification
1B
1C
II
III
IV
V
class IB
action: sodium channel blockers (no change in phase 0)
e. g. lidocaine
]
class IC
action: sodium channel blockers (marked phase 0)
e. g. flecainade and propafenone
class II
action: B blocker
e. g. bisoprolol, metoprolol, propranolol
class III
action: potassium channel blockers- prologed repolarisation
e. g. amiodarone, sotalol
class IV
action: calcium channel blcoker
e. g. verapamil, dilitiazem
class V
action: variable
e. g. adenosine, digoxin, atropin, ivabradine
most efficacious drug
- Amiodarone is the best
most tolerable drug
B blockers most tolerable, amiodarone least (e.g. sunburn and breathlessness)
when are class 1B agents used e.g. lidocaine
- Ventricular tachycardia (in relation to a scar in the heart- ischaemia)
- Not used in atrial arrhythmias or AV junctional arrhythmias
ventricular tachycardia and class 1B agents e.g. lidocaine
- Damaged areas of myocardium may be depolarised and fire automatically
- More Na+ channels are open in depolarised tissue
- Lidocaine blocks these sodium channels
- Preventing automatic firing of depolarised ventricular tissue
- Effect on cardiac activity
- Fast binding offset kinetics
- In normal tissue
- No change in phase 0 (no tonic block)
- ADP slightly decreased
- Fast beating or Ischaemic tissue
- Increase threshold for Na
- Decrease phase 0 conduction
- Effect on ECG
- None in normal
- In fast beating or ischaemic = increase QRS
adverse drug repsonse clas 1B agents
- Less proarrhythmic than Class 1A (less QT effect)
- CNS effect: dizziness, drowsiness
- Abdominal upsets
when are class 1C agents used e.g. flecainide
- Wide spectrum
- Supraventricular arrhythmias
- Atrial fibrillation
- Atrial flutter
- Premature ventricular contractions
- Wolff- Parkinson-White syndrome (ectopic beats)
- Supraventricular arrhythmias
MOA of class 1C agents e.g. flecainide
- Na+ channel blocker
- Effect on cardiac activity
- Very slow binding offset kinetics (>10s)
- In normal tissue
- Decreased phase 0 (Na+)
- Decreased automaticity
- In rapidly depolarising atrial tissue
- Increased APD (K+) and increased refractory period
- Effect on ECG (beware of Torsades de Pointe)
- Increase PR
- Increase QRS
- Increase refractory
ADR class 1C e.g. flecainide
- Pro-arrhythmia and sudden death especially with chronic use and ins structural hear disease
- Increase ventricular response to supraventricular arrhythmias (flutter)
- CNS and GI effects like other local anaesthetics
contraindication of class 1C
- Coronary heart disease
- Structural heart disease e.g. previous MI